OSOM iFOB Test is a rapid qualitative test for the immunochemical detection of fecal occult blood/human hemoglobin (hHb) in human fecal specimens as an aid in the diagnosis of gastrointestinal disorders such as: diverticulitis, colitis, polyps, and colorectal cancer. The device is suitable for use in laboratories and physician’s offices. The test is recommended for use in routine physical examination, new patient screening at admission and screening and monitoring any suspected colorectal cancer and/or gastrointestinal bleeding from any source.
March is Colorectal Cancer Awareness Month, a time dedicated to raising awareness about one of the most preventable yet still highly prevalent cancers in the United States.
According to the American Cancer Society, colorectal cancer remains the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths among men and women combined. Despite these sobering statistics, colorectal cancer is uniquely positioned for effective prevention through routine screening and early intervention.
